ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VEC Vectura Group Plc

164.80
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Share Discussion Threads

Showing 7176 to 7200 of 12050 messages
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older
DateSubjectAuthorDiscuss
12/4/2018
20:01
Another relatively high volume day with a close at, or near, high of day. A big uncross trade and post market transfer. Long may this continue.
polaris
12/4/2018
20:00
VEC is looking at options in China. They bought into a JV and have basically written those costs off as some kind of market study plus costs for necessary equipment. China is a bit of an enigma for most Western companies and this little foray was a 'what can we learn' experience. Who knows if it will lead to anything concrete in future?
polaris
12/4/2018
19:26
Extracted from today's risk assessment RNS. Anyone understand what this actually means and what the implications are? RELATED-PARTY TRANSACTIONSAssociates In order to finalise the valuation process of the Group's Chinese associate, costs of £1.6m have been incurred comprising £0.6m for the cost of new equipment and a £1.0m waiver of a loan previously made to the associate. These contributions are considered arms-length related party transactions, necessary to finalise the valuation process.
dontay
12/4/2018
10:53
That is a standard risk assessment update. I have had to do a few of those over the years. They are both tedious and necessary in long-term projects and business. I think VEC are just being prudent here. It is not price senstive to my mind, unless one of the risks happens. All the generic Advair stuff was already in the public domain and so the price impact already known.
polaris
12/4/2018
10:30
No. Just playing by the book.
cumnor
12/4/2018
10:29
Can't see anything we don't know - rapid look through. Am I wrong?
richtea2517
12/4/2018
10:27
Popper Joe-as I said, old news, but risk assessments are downbeat, perhaps we should have reward assessments as well. Without them, I rely for those on the excellent posts by polaris and others.
alexchry
12/4/2018
10:14
I don't think there is anything in that RNS that hadn't previously been announced?
popper joe
12/4/2018
10:14
pob-risk assessment isn't the most inspiring of reads particularly when they say that due to the delay in generic advair they can't afford the risk of developing two products on their own and must seek partners next year. Old news, I know, so hopefully little or no impact today.
alexchry
12/4/2018
09:50
Well it looks to me someone knew that rns was coming. not what they wanted and price drops .
pooroldboy55
12/4/2018
09:06
Don't know what all the panic was about. Steady growth lower risk rating and disappointment baked into the price. The chart is looking interesting all the way up to circa 105 and then 120... not saying we'll get there but relaying the pattern.
rathean
11/4/2018
22:52
Thanks Polaris will do - the future of respiratory for GSK is the Ellipta, so the consequences are huge
bilster1
11/4/2018
22:01
Bilster1 - start with the announcements re the litigation over last 12 months and then read the 2017FY report, watch the results presentation and listen to the webcast. There are quite a few posts on those days covering the major points. That should clear most of it up.
polaris
11/4/2018
21:24
VEC stock shorted seems to have considerably reduced, falling from 7.7 to 3.3%
dontay
11/4/2018
18:23
Can anyone update me on what is going on between GSK and Vectura regarding the Ellipta - I know how important the Ellipta is to GSKs respiratory portfolio going forward and all its new molecules will be delivered by this device.
bilster1
11/4/2018
17:03
I smell encouragement
richtea2517
11/4/2018
16:36
Very interesting 1.3 million buy at the Bell 88p
best1467
11/4/2018
12:10
indeed the seller seems to have taken a few days off.
s1zematters
11/4/2018
12:03
Let's hope those Torygraph 175p GSK rumours come true!
justiceforthemany
11/4/2018
10:34
We have already come a long way from results day! I'm just heading to the airport to return home from Munich and a big smile on the face with the share price action here since i jumped in at the low 70s. Might have to have (another) wheat beer!
polaris
11/4/2018
10:22
Looks like this could turn into a garden party.
pooroldboy55
11/4/2018
10:07
If its near Oxfordshire them i'm also in as now living near Wantage. ;-)
polaris
11/4/2018
09:46
Hi cityfarmer best be in the summer as its always cold in Chippy.
pooroldboy55
11/4/2018
09:45
See POB. We all need you to wait for £2.
richtea2517
11/4/2018
09:44
Is this going to £2?!!!!
brucie5
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older

Your Recent History

Delayed Upgrade Clock